Abstract | BACKGROUND: Esophageal stenting represents a new strategy to avoid multiple dilations owing to stenosis relapse. Our custom stent improves esophageal motility unlike the widespread self-expandable plastic esophageal stents. The aim of the study was to confirm the efficacy of treatment with silicone custom stents in esophageal stenosis (ES) in pediatric patients. METHODS: A silicone stent of 7-, 9-, or 12.7-mm external diameter is built coaxially on a nasogastric tube that guarantees the correct position. The 2 ends are tailored to allow food passage between stent and esophageal wall. All patients received dexamethasone (2 mg/kg per day) for 3 days and ranitidine/ proton-pump inhibitors. Study approval was obtained from our ethical board. RESULTS: From 1988 to 2010, 79 patients with ES, mean age 35.4 months (3-125 months), underwent esophageal hydrostatic/Savary dilations and custom- stent placement, left in place for at least 40 days. Stenting was effective in 70 (88.6%) of 79 patients. Fifty percent of the patients with effective treatment received only one dilation for stent placement. Fourteen patients received more stents successfully. There was one stent-related major complication. CONCLUSION: Our custom stent improves treatment in ES. In caustic injuries, ES stenting represents the first option. In postsurgical ES, we stent after at least 5 dilations.
|
Authors | Francesca Foschia, Paola De Angelis, Filippo Torroni, Erminia Romeo, Tamara Caldaro, Giovanni Federici di Abriola, Alessandro Pane, Maria Stella Fiorenza, Francesco De Peppo, Luigi Dall'Oglio |
Journal | Journal of pediatric surgery
(J Pediatr Surg)
Vol. 46
Issue 5
Pg. 848-53
(May 2011)
ISSN: 1531-5037 [Electronic] United States |
PMID | 21616239
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Caustics
- Proton Pump Inhibitors
- Dexamethasone
|
Topics |
- Antibiotic Prophylaxis
- Burns, Chemical
(therapy)
- Caustics
(adverse effects)
- Child
- Child, Preschool
- Dexamethasone
(administration & dosage, therapeutic use)
- Dilatation
(instrumentation)
- Equipment Design
- Esophageal Motility Disorders
(prevention & control)
- Esophageal Perforation
(etiology)
- Esophageal Stenosis
(chemically induced, etiology, therapy)
- Female
- Humans
- Infant
- Intubation, Gastrointestinal
- Male
- Postoperative Complications
(therapy)
- Proton Pump Inhibitors
(administration & dosage, therapeutic use)
- Radiation Injuries
(therapy)
- Stents
(adverse effects)
|